Skip to main content

. 1989 Sep;60(3):419–420. doi: 10.1038/bjc.1989.297

Tumour marker antigens during menses and pregnancy.

Y Touitou ¹, Y Darbois ¹, A Bogdan ¹, A AuzÃ©by ¹, S Keusseoglou ¹

PMCID: PMC2247203 PMID: 2789952

419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Halila H., Stenman U. H., Seppälä M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer. 1986 Apr 1;57(7):1327–1329. doi: 10.1002/1097-0142(19860401)57:7<1327::aid-cncr2820570713>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
Jäger W., Meier C., Wildt L., Sauerbrei W., Lang N. CA-125 serum concentrations during the menstrual cycle. Fertil Steril. 1988 Aug;50(2):223–227. doi: 10.1016/s0015-0282(16)60063-8. [DOI] [PubMed] [Google Scholar]
Niloff J. M., Knapp R. C., Schaetzl E., Reynolds C., Bast R. C., Jr CA125 antigen levels in obstetric and gynecologic patients. Obstet Gynecol. 1984 Nov;64(5):703–707. [PubMed] [Google Scholar]
Pittaway D. E., Fayez J. A. Serum CA-125 antigen levels increase during menses. Am J Obstet Gynecol. 1987 Jan;156(1):75–76. doi: 10.1016/0002-9378(87)90207-9. [DOI] [PubMed] [Google Scholar]
Touitou Y., Bogdan A. Etude critique des marqueurs tumoraux récents. Bull Cancer. 1988;75(3):247–262. [PubMed] [Google Scholar]
Touitou Y., Bogdan A. Tumor markers in non-malignant diseases. Eur J Cancer Clin Oncol. 1988 Jul;24(7):1083–1091. doi: 10.1016/0277-5379(88)90113-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES